Considering the inconsistent trend of results and significant heterogeneity in the subgroups, a lack of uniform detect methods and evaluation criteria may be a restriction for a pooled analysis to confidently illustrate the prognostic significance of YKL-40 for OS in breast cancer. This evidence concerns the gene CHI3L1 and breast cancer.